{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:41:03Z","timestamp":1792114863001,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ecl.2025.03.016","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T23:35:53Z","timestamp":1749512153000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Interaction Between Sex and Thyroid Cancer Development and Management"],"prefix":"10.1016","volume":"54","author":[{"given":"Farah I.","family":"Kitana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Shobab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2025.03.016_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"issue":"9356","key":"10.1016\/j.ecl.2025.03.016_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2025.03.016_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11<2156::AID-CNCR16>3.0.CO;2-Y","article-title":"Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology","volume":"80","author":"Farahati","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2025.03.016_bib4","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2011-2864","article-title":"The impact of age and gender on papillary thyroid cancer survival","volume":"97","author":"Jonklaas","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.03.016_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41568-021-00348-y","article-title":"Sex disparities matter in cancer development and therapy","volume":"21","author":"Haupt","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ecl.2025.03.016_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2025.03.016_bib7","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2025.03.016_bib8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/thy.2009.1611","article-title":"The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2025.03.016_bib9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/thy.2019.0075","article-title":"Clinical, pathological, and molecular profiling of radioactive iodine refractory differentiated thyroid cancer","volume":"29","author":"Shobab","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2025.03.016_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijms21010010","article-title":"Multikinase inhibitor treatment in thyroid cancer","volume":"21","author":"Ancker","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ecl.2025.03.016_bib11","first-page":"24","article-title":"Papillary carcinoma of the thyroid","volume":"55","author":"Carcangiu","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1210\/jc.2009-1536","article-title":"Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question","volume":"95","author":"Elisei","year":"2010","journal-title":"JCEM"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib13","first-page":"1234","article-title":"Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway","volume":"51","author":"Akslen","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ecl.2025.03.016_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12672-018-0340-y","article-title":"Impact of gender and age on the prognosis of differentiated thyroid carcinoma: a retrospective analysis based on SEER","volume":"9","author":"Zhang","year":"2018","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ecl.2025.03.016_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0002-9610(05)80539-2","article-title":"Survival discriminants for differentiated thyroid cancer","volume":"160","author":"Cunningham","year":"1990","journal-title":"Am J Surg"},{"key":"10.1016\/j.ecl.2025.03.016_bib16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1055-9965.EPI-08-0976","article-title":"Gender is an age- specific effect modifier for papillary cancers of the thyroid gland","volume":"18","author":"Kilfoy","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archsurg.133.4.419","article-title":"Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment","volume":"133","author":"Sanders","year":"1998","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.016_bib18","first-page":"744","article-title":"Immunohistochemical study of oestrogen receptors in 351 human thyroid glands","volume":"48","author":"Tavangar","year":"2007","journal-title":"Singapore Med J"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/1097-0142(19930815)72:4<1364::AID-CNCR2820720435>3.0.CO;2-2","article-title":"Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma","volume":"72","author":"Inoue","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.016_bib20","first-page":"1072","article-title":"Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms","volume":"86","author":"Manole","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.03.016_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4061\/2011\/875125","article-title":"Role of estrogen in thyroid function and growth regulation","volume":"2011","author":"Santin","year":"2011","journal-title":"J Thyroid Res"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/ERC-11-0389","article-title":"Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient\u2019s risk","volume":"19","author":"Magri","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/path.2297","article-title":"The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas","volume":"214","author":"Zeng","year":"2008","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.016_bib24","first-page":"183","article-title":"Expression of estrogen and progesterone receptors in papillary thyroid carcinoma","volume":"7","author":"Jalali-Nadoushan","year":"2016","journal-title":"Caspian J Intern Med"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.016_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/iep.12266","article-title":"Reduced expression of oestrogen receptor-beta is associated with tumour invasion and metastasis in oestrogen receptor-alpha-negative human papillary thyroid carcinoma","volume":"99","author":"Dong","year":"2018","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ecl.2025.03.016_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/1471-2407-14-383","article-title":"Differential expression patterns and clinical significance of estrogen receptor-alpha and beta in papillary thyroid carcinoma","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.016_bib27","doi-asserted-by":"crossref","first-page":"BR351","DOI":"10.12659\/MSM.883344","article-title":"Differential expression patterns of estrogen receptor (ER)-beta splice variants between papillary thyroid cancer and nodular thyroid goiter","volume":"18","author":"Dong","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ecl.2025.03.016_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/ERC-11-0389","article-title":"Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient\u2019s risk","volume":"19","author":"Magri","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2025.03.016_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/path.2297","article-title":"The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcino- mas","volume":"214","author":"Zeng","year":"2008","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.016_bib30","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cmet.2020.05.008","article-title":"The major pre- and postmenopausal estrogens play opposing roles in obesity-driven mammary inflammation and breast cancer development","volume":"31","author":"Qureshi","year":"2020","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.ecl.2025.03.016_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111672","article-title":"Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis","volume":"41","author":"Qureshi","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.ecl.2025.03.016_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2025.03.016_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fgene.2020.00808","article-title":"Gender differential transcriptome in gastric and thyroid cancers","volume":"11","author":"Sousa","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.ecl.2025.03.016_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccell.2016.04.001","article-title":"Comprehensive characterization of molecular differences in cancer be- tween male and female patients","volume":"29","author":"Yuan","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ecl.2025.03.016_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.32072","article-title":"Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality","volume":"145","author":"Watanabe","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ecl.2025.03.016_bib36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","article-title":"KDM5 Histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance","volume":"34","author":"Hinohara","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ecl.2025.03.016_bib37","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1158\/1078-0432.CCR-20-1741","article-title":"X- and Y-linked chromatin-modifying genes as regulators of sex- specific cancer incidence and prognosis","volume":"26","author":"Tricarico","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ecl.2025.03.016_bib38","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.1600420113","article-title":"Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression","volume":"113","author":"Komura","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ecl.2025.03.016_bib39","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI96769","article-title":"ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D","volume":"128","author":"Komura","year":"2018","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/carcin\/bgv001","article-title":"Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity","volume":"36","author":"Zhang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ecl.2025.03.016_bib41","first-page":"6763","article-title":"EGFR inhibition enhances the antitumor efficacy of a selective BRAF V600E inhibitor in thyroid cancer cell lines","volume":"15","author":"Jia","year":"2018","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.ecl.2025.03.016_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071260","article-title":"Sex-specific expression of histone lysine demethylases (KDMs) in thyroid cancer","volume":"16","author":"Shobab","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ecl.2025.03.016_bib43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41590-023-01463-8","article-title":"The X-linked epigenetic regulator UTX controls NK cell-intrinsic sex differences","volume":"24","author":"Cheng","year":"2023","journal-title":"Nat Immunol"},{"issue":"20","key":"10.1016\/j.ecl.2025.03.016_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00341-20","article-title":"Lysine demethylase KDM6A in differentiation, development, and cancer","volume":"40","author":"Tran","year":"2020","journal-title":"Mol Cell Biol"},{"issue":"39","key":"10.1016\/j.ecl.2025.03.016_bib45","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2017.157","article-title":"UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor","volume":"36","author":"Xie","year":"2017","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ecl.2025.03.016_bib46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.016_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.it.2013.10.006","article-title":"SeXX matters in immunity","volume":"35","author":"Markle","year":"2014","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.016_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BOR.0000000000000564","article-title":"Sex bias in autoimmunity","volume":"31","author":"Billi","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.016_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41581-023-00787-w","article-title":"Mechanisms and consequences of sex differences in immune responses","volume":"20","author":"Dunn","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.016_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/intimm\/dxl151","article-title":"Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)","volume":"19","author":"Polanczyk","year":"2007","journal-title":"Int Immunol"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.016_bib51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.autrev.2010.04.003","article-title":"PD-1, gender, and autoimmunity","volume":"9","author":"Dinesh","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ecl.2025.03.016_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.582863","article-title":"Estrogen receptor downregulates expression of PD-1\/PD-L1 and infiltration of CD8(+) T cells by inhibiting IL-17 signaling transduction in breast cancer","volume":"10","author":"Shuai","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.016_bib53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaoncol.2018.5904","article-title":"Association of patient sex with efficacy of immune checkpoint inhibitors and overall survival in advanced cancers: a systematic review and meta-analysis","volume":"5","author":"Wallis","year":"2019","journal-title":"JAMA Oncol"},{"issue":"59","key":"10.1016\/j.ecl.2025.03.016_bib54","doi-asserted-by":"crossref","first-page":"99336","DOI":"10.18632\/oncotarget.22242","article-title":"The sexist behaviour of immune checkpoint inhibitors in cancer therapy?","volume":"8","author":"Botticelli","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.016_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12534","article-title":"Association of sex, age, and eastern cooperative oncology group performance status with survival benefit of cancer immunotherapy in randomized clinical trials: a systematic review and meta-analysis","volume":"3","author":"Yang","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.016_bib56","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41467-020-15679-x","article-title":"Sex-associated molecular differences for cancer immunotherapy","volume":"11","author":"Ye","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ecl.2025.03.016_bib57","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/jc.2017-00058","article-title":"Thyroid-specific T cells in patients with differentiated thyroid cancer: implications for immune-based therapies?","volume":"102","author":"French","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.03.016_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2213-8587(16)30277-7","article-title":"Leveraging the immune system to treat advanced thyroid cancers","volume":"5","author":"French","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ecl.2025.03.016_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1438235","article-title":"Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ecl.2025.03.016_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.016_bib61","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat Commun"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:03:23Z","timestamp":1753484603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852925000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0889852925000386"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.03.016","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Interaction Between Sex and Thyroid Cancer Development and Management","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}